A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma
Clinical trial NCT05573802 · RECRUITING
Trial details
- NCT number
- NCT05573802
- Sponsor
- Hellenic Society of Hematology
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-14
- Primary completion
- 2026-10-31
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.